Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelitis NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04693286
What this trial is testing

Clinical Trial of Novel OPV2 Vaccine

Who this might be right for
Poliomyelitis
International Centre for Diarrhoeal Disease Research, Bangladesh 330
Large-scale testing (Phase 3)Study completedNCT03032419
What this trial is testing

Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months

Who this might be right for
Poliomyelitis
Statens Serum Institut 1,002
Not applicableLooking for participantsNCT03900221
What this trial is testing

French Registry for Monitoring Pregnancies for Multiple Sclerosis

Who this might be right for
Sclerosis, MultipleNeuromyelitis Optica Spectrum DisorderMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders+1 more
Hospices Civils de Lyon 1,500
Not applicableNot Yet RecruitingNCT07526298
What this trial is testing

Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
IRCCS San Raffaele 50
Post-approval studies (Phase 4)Ended earlyNCT05269667
What this trial is testing

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention

Who this might be right for
Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche 4
Post-approval studies (Phase 4)Study completedNCT00802867
What this trial is testing

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 989
Large-scale testing (Phase 3)Study completedNCT00092469
What this trial is testing

Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Merck Sharp & Dohme LLC 151
Not applicableUnknownNCT05303545
What this trial is testing

Physical Activity in People With Sequelae of Poliomyelitis

Who this might be right for
Poliomyelitis
Institut de Sante Parasport Connecte Synergies 200
Not applicableStudy completedNCT05083039
What this trial is testing

Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19

Who this might be right for
Coronavirus InfectionsVaccinePolio
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products 1,500
Not applicableLooking for participantsNCT05663008
What this trial is testing

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)Postpoliomyelitis SyndromeSpinal Muscular Atrophy
University of Dublin, Trinity College 400
Not applicableUnknownNCT04822623
What this trial is testing

Imaging Evaluation of Central Nervous Autoimmune Diseases

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder
Qilu Hospital of Shandong University 300
Not applicableStudy completedNCT04177485
What this trial is testing

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

Who this might be right for
DiphtheriaTetanusPertussis+4 more
Centers for Disease Control and Prevention 1,962
Early research (Phase 1)Looking for participantsNCT06620809
What this trial is testing

The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Tongji Hospital 69
Large-scale testing (Phase 3)UnknownNCT04620772
What this trial is testing

Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis

Who this might be right for
TuberculosisTubercular MeningitisArachnoiditis; Tuberculous (Etiology)
All India Institute of Medical Sciences 40
Large-scale testing (Phase 3)Study completedNCT01537575
What this trial is testing

Intravenous Immunoglobulins for Post-Polio Syndrome

Who this might be right for
Post-polio Syndrome
Azienda Ospedaliera Universitaria Integrata Verona 50
Post-approval studies (Phase 4)Looking for participantsNCT07457060
What this trial is testing

Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

Who this might be right for
Poliomyelitis
Sinovac Biotech Co., Ltd 480
Not applicableLooking for participantsNCT06474520
What this trial is testing

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

Who this might be right for
Idiopathic Inflammatory Demyelinating DiseaseMultiple SclerosisNeuromyelitis Optica Spectrum Disorder+2 more
Tongji Hospital 250
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000
Early research (Phase 1)Study completedNCT02276963
What this trial is testing

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Johns Hopkins University 6
Post-approval studies (Phase 4)Study completedNCT01491087
What this trial is testing

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 900
Next Page